For example, drugs that target VEGFA may induce PAH, erlotinib (target EGFR) was ineffective in animal model, and hyaluronidase (target TGFβ-1) could not be delivered to lung tissue in its present formulation. The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.